Zyprexa
Transitioning Patients to Olanzapine LAI
Zyprexa (olanzapine) is a well-established atypical antipsychotic that offers prescribers a highly effective and well-tolerated option for managing schizophrenia and bipolar I disorder (manic or mixed episodes).
Its robust clinical profile, supported by numerous studies, underscores its efficacy in achieving fast symptomatic relief and maintaining long-term clinical improvement for appropriate patients.
CHEPLAPHARM is committed to ensuring the continued availability of Zyprexa, helping clinicians deliver optimal patient care.